Tech Company Financing Transactions

Ilkos Therapeutics Funding Round

Ilkos Therapeutics secured a $21 million funding round on 9/30/2016. Investors included CTI Life Sciences Fund, Fonds de solidarite FTQ and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Laval QC, H7M 1B2
Canada

Phone

Undisclosed

Website

Email Address

Not Recorded

Overview

The creation of ILKOS THERAPEUTICS will make it possible to continue the clinical development of an innovative drug, which was deprioritized from Servier's R&D strategic priorities. This innovative project reflects the evolution of our business model.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mark Beaudet

        

Browse more venture capital transactions:

Prev: 9/30/2016: Creatively Alive venture capital transaction
Next: 9/30/2016: Cobalt IO venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary